What is the current Price Target for the Rocket Pharmaceuticals, Inc. stock?

The average Rocket Pharmaceuticals, Inc. target price is $40.53. This is 543.39% higher than the current stock price. The highest price target is 773.02%, the lowest is 138.10%. 15 Analysts have issued a price target Rocket Pharmaceuticals, Inc. 2026 .

How high will the Rocket Pharmaceuticals, Inc. stock rise?

No reliable answer can be given as to how high the Rocket Pharmaceuticals, Inc. stock will rise. The performance of stocks, including the Rocket Pharmaceuticals, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Rocket Pharmaceuticals, Inc. stock today?

The performance of Rocket Pharmaceuticals, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Rocket Pharmaceuticals, Inc. stock fall?

The decline in Rocket Pharmaceuticals, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Rocket Pharmaceuticals, Inc. Forecast, price target & analysts

$5.66

10.24% today

Nasdaq, Apr 03, 06:47 pm CET

ISIN

US77313F1066

Symbol

RCKT

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Rocket Pharmaceuticals, Inc. Target price 2025 - Analyst rating & recommendation

Rocket Pharmaceuticals, Inc. Classifications & Recommendation:

Buy

94%

Hold

Rocket Pharmaceuticals, Inc. Price Target

Target Price	$40.53
Price	$6.30
Potential	543.39% register free of charge
Number of Estimates	15

	15 Analysts have issued a price target Rocket Pharmaceuticals, Inc. 2026 . The average Rocket Pharmaceuticals, Inc. target price is $40.53. This is 543.39% register free of charge higher than the current stock price. The highest price target is $55.00 773.02% register free of charge , the lowest is $15.00 138.10% register free of charge .
	A rating was issued by 17 analysts: 16 Analysts recommend Rocket Pharmaceuticals, Inc. to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Rocket Pharmaceuticals, Inc. stock has an average upside potential 2026 of 543.39% register free of charge . Most analysts recommend the Rocket Pharmaceuticals, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-2.73	-2.25
	6.51%	17.58%
P/E		negative
EV/Sales		7.34

5 Analysts have issued a Rocket Pharmaceuticals, Inc. forecast for earnings per share. The average Rocket Pharmaceuticals, Inc. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-2.73	6.51%
2025	$-2.25 17.58% Unlock
2026	$-1.32 41.33% Unlock
2027	$1.07 181.06% Unlock
2028	$2.80 161.68% Unlock
2029	$5.50 96.43% Unlock

Current	-2.30	74.92%
2025	-2.80 21.74% Unlock
2026	-4.78 70.71% Unlock
2027	5.89 223.22% Unlock
2028	2.25 61.80% Unlock
2029	1.15 48.89% Unlock

Rocket Pharmaceuticals, Inc....

Current Rocket Pharmaceuticals, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
BMO Capital	Locked ➜ Locked	Locked	Mar 12 2025
Goldman Sachs	Locked ➜ Locked	Locked	Mar 03 2025
Scotiabank	Locked ➜ Locked	Locked	Mar 03 2025
Canaccord Genuity	Locked ➜ Locked	Locked	Mar 03 2025
Chardan Capital	Locked ➜ Locked	Locked	Feb 28 2025
Needham	Locked ➜ Locked	Locked	Feb 28 2025
Jefferies	Locked ➜ Locked	Locked	Dec 18 2024

Analyst Rating	Date
Locked BMO Capital: Locked ➜ Locked	Mar 12 2025
Locked Goldman Sachs: Locked ➜ Locked	Mar 03 2025
Locked Scotiabank: Locked ➜ Locked	Mar 03 2025
Locked Canaccord Genuity: Locked ➜ Locked	Mar 03 2025
Locked Chardan Capital: Locked ➜ Locked	Feb 28 2025
Locked Needham: Locked ➜ Locked	Feb 28 2025
Locked Jefferies: Locked ➜ Locked	Dec 18 2024

Discover more stocks with a high price target

Novo Nordisk 75.12%

Coinbase Global, Inc. 71.30%

BioNTech SE - ADR 48.29%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now